Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Acquisitions Number:
Made Acquisitions
Founded Date:
2015-01-01
Last Funding Type:
Secondary Market
Headquarters:
South San Francisco, California, United States
Investors Number:
6
Employee Number:
1001-5000
Industry:
End-to-End Drug Development
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-09-28
Number Of Exists:
4
Funding Status:
Private Equity
Total Funding:
3500000000.0